14th European Congress of Clinical Microbiology and Infectious ...

Poster Sessions Sunday, May 2, 2004
P446 Comparison of additional antibacterial usage
in patients with community-acquired
pneumonia receiving telithromycin or
clarithromycin: results from two double-blind,
randomised clinical trials
P.G. Davey, M. Niederman, J. Paladino, C. Taneja,
G. Oster, J. Stewart, J. Chang
(Dundee, UK; Mineola, Amherst, Brookline, USA;
Quebec, CAN; Bridgewater, USA)
P447 Seroprevalance of Chlamydophilia
pneumoniae infection in patients with
chronic stable asthma
M. Aslan, K. Güven, G. Saglam, S. Altun,
S. Saribas, B. Müsellim, B. Gemicioglu,
B. Kocazeybek (Istanbul, TR)
P448 Severe community-acquired pneumonia:
impact of empirical antimicrobial treatment
on outcome
M. Daganou, P. Bakakos, A. Sakellaropoulos,
M. Kompoti, A. Paridou, M. Ktena, A. Rassidakis
(Athens, GR)
P449 Efficacy of linezolid for the treatment of
pneumonia caused by penicillin- (PRSP) or
multi-drug resistant Streptococcus pneumoniae
K. Tack, M. Ijzerman, R. Croos-Dabrera
(Ann Arbor, USA)
P450 Pathogenic role, epidemiology, and susceptibility
to antimicrobial agents of Neisseria
meningitidis isolated from lower respiratory
tract secretions of adult patients
E. Cercenado, B. Padilla, P. Martín-Rabadán,
N. García-Escribano, O. Pérez-Olaso, E. Bouza
(Madrid, E)
P451 Efficacy of a 7-day course of oral telithromycin
800 mg once daily in community-acquired
pneumonia caused by resistant Streptococcus
pneumoniae
C. Fogarty, D. van Rensburg, C. de Salvo,
M. Rangaraju, R. Nusrat (Spartanburg, USA;
Witbank, ZA; Federal Capital, AR; Romainville, F;
Bridgewater, USA)
P452 Efficacy of telithromycin in patients with
community-acquired respiratory tract
infections caused by Streptococcus
pneumoniae, including resistant strains
C. Fogarty, P. Buchanan, M. Aubier, M. Baz,
D. van Rensburg, M. Rangaraju, R. Nusrat
(Spartanburg, Eugene, USA; Paris, F; Fresno, USA;
Witbank, ZA; Romainville, F; Bridgewater, USA)
page 66 Final Programme
P453 Epidemiology of hospitalised patients with
AECB (acute exacerbation of chronic
bronchitis) and Gram-negative bacilli in the
sputum
I. Gómez De Argila, C. Garcia Vidal, P. Almagro
Mena, H. Monzón Camps, L. Cuadra Llompart,
L. Canales, E. Cuchí, J. Garau (Terrassa, E)
P454 Procalcitonin and neopterin correlates with
aetiology and severity in adults with
pneumonia
C. Prat, J. Domínguez, J. Ruiz-Manzano,
S. Blanco, R. Rivelo, F. Andreo, V Ausina
(Badalona, E)
P455 Rapid centrifugal method for Legionella
antigen concentration in urine samples
J. Domínguez, S. Blanco, C. Prat, R. Rivelo,
M.D. Sánchez, M.A. Pallarés, V. Ausina
(Badalona, E)
P456 Usefulness of PORT-score to decide
hospitalisation of patients with communityacquired
pneumonia: analysis of 509
consecutive patients classified in categories I
and II
C. Font, E. García-Vázquez, M. Cavalcanti,
M. Camps, I. Aldabó, C. Esquinas, M.A. Marcos,
J. Mensa, A. Torres, J. Puig (Barcelona, E)
P457 Sputum color as marker for clinical success in
patients with acute exacerbation of chronic
bronchitis (AECB) treated with levofloxacin
H. Lode, J. Eller, K. Roscher (Berlin, D)
P458 Outcome and clinical differences between
pneumococcal pneumonia with and without
bacteraemia
F. Jover, J.M. Cuadrado, L. Andreu, M. Rodríguez,
R. Cañizares, S. Martinez, V. Ortiz, P. Roig
(Alicante, E)
P459 Comparative assessment of moxifloxacin and
macrolides in acute exacerbation of chronic
bronchitis: clinical efficacy and influence on
the long-term prognosis
S. Yakovlev, L. Dvoretsky, V. Nonikov,
A. Strekachev, N. Dubrovskaya (Moscow, RUS)